Promising.
Early trial data shows a drug developed using artificial intelligence can slow the growth of cancer in clinical trials.
The data, presented at the American Society of Clinical Oncology conference, showed some tumours shrank by around a quarter.
The compound will now be taken into more advanced trials.
Read more